Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Soil Amendments with Spearmint, Peppermint and Rosemary Enhance the Community of Free-Living Nematodes and Improve Soil Quality, While Having Strikingly Different Effects on Plant Growth.
Life (Basel). 2022 Jul 26;12(8):1121. doi: 10.3390/life12081121.
Life (Basel). 2022.
PMID: 35892923
Free PMC article.
The Invasion of Alien Populations of Solanum elaeagnifolium in Two Mediterranean Habitats Modifies the Soil Communities in Different Ways.
Karmezi M, Krigas N, Papatheodorou EM, Argyropoulou MD.
Karmezi M, et al. Among authors: argyropoulou md.
Plants (Basel). 2023 May 31;12(11):2193. doi: 10.3390/plants12112193.
Plants (Basel). 2023.
PMID: 37299172
Free PMC article.
Item in Clipboard
Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab.
Stergianou D, Tzanetakou V, Argyropoulou M, Kanni T, Bagos PG, Giamarellos-Bourboulis EJ.
Stergianou D, et al.
Dermatology. 2021;237(3):372-377. doi: 10.1159/000512617. Epub 2021 Jan 5.
Dermatology. 2021.
PMID: 33401280
Item in Clipboard
MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study.
Kanni T, Argyropoulou M, Spyridopoulos T, Pistiki A, Stecher M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ.
Kanni T, et al.
J Invest Dermatol. 2018 Apr;138(4):795-801. doi: 10.1016/j.jid.2017.10.030. Epub 2017 Nov 10.
J Invest Dermatol. 2018.
PMID: 29129600
Free article.
Clinical Trial.
Item in Clipboard
Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort.
Argyropoulou M, Kanni T, Kyprianou M, Melachroinopoulos N, Giamarellos-Bourboulis EJ.
Argyropoulou M, et al.
Br J Dermatol. 2019 May;180(5):1161-1168. doi: 10.1111/bjd.17151. Epub 2018 Nov 4.
Br J Dermatol. 2019.
PMID: 30192377
Item in Clipboard
Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab.
Giamarellos-Bourboulis EJ, Argyropoulou M, Kanni T, Spyridopoulos T, Otto I, Zenker O, Guo R, Riedemann NC.
Giamarellos-Bourboulis EJ, et al.
Br J Dermatol. 2020 Jul;183(1):176-178. doi: 10.1111/bjd.18877. Epub 2020 Mar 4.
Br J Dermatol. 2020.
PMID: 31954061
Clinical Trial.
No abstract available.
Item in Clipboard
MABp1 targeting interleukin-1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period.
Kanni T, Argyropoulou M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ.
Kanni T, et al.
Clin Exp Dermatol. 2021 Jan;46(1):162-163. doi: 10.1111/ced.14333. Epub 2020 Jul 27.
Clin Exp Dermatol. 2021.
PMID: 32516832
No abstract available.
Item in Clipboard
Cite
Cite